ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase II/III Randomized, Placebo-controlled Trial of Arimoclomol in SOD1 Positive Familial Amyotrophic Lateral Sclerosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00706147
Recruitment Status : Completed
First Posted : June 27, 2008
Last Update Posted : August 18, 2017
Sponsor:
Collaborator:
Massachusetts General Hospital
Information provided by (Responsible Party):
Michael Benatar, University of Miami

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2014
  Actual Study Completion Date : November 2016
  Certification/Extension First Submitted : August 10, 2017